Current Stem Cell Research & Therapy
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 6
Author(s): Helen O’Neill
Affiliation:
Export Options
About this article
Cite this article as:
O’Neill Helen, Meet Our Editorial Board Member, Current Stem Cell Research & Therapy 2015; 10 (6) . https://dx.doi.org/10.2174/1574888X1006150917164133
DOI https://dx.doi.org/10.2174/1574888X1006150917164133 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
16
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis
Current Drug Metabolism Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems
Current Bioinformatics Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Potential Application of Gene Therapy to X-Linked Agammaglobulinemia
Current Gene Therapy STAT3 Regulation of Glioblastoma Pathogenesis
Current Molecular Medicine Strategies for Increasing the Solubility and Bioavailability of Anticancer Compounds: β-Lapachone and Other Naphthoquinones
Current Pharmaceutical Design Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Signaling Pathways Associated with Inflammatory Bowel Disease
Recent Patents on Inflammation & Allergy Drug Discovery The Immunoproteasome as a Therapeutic Target for Hematological Malignancies
Current Cancer Drug Targets Synthetic Peptides As Non-Viral DNA Vectors
Current Gene Therapy Hematopoietic Colony Stimulating Factors in Cardiovascular and Pulmonary Remodeling: Promoters or Inhibitors?
Current Pharmaceutical Design Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Protein Profile of Fibroblasts: The Role of Proteomics
Current Proteomics Role of Active Drug Transporters in Refractory Multiple Myeloma
Current Topics in Medicinal Chemistry An Advanced Computational Evaluation for the Most Biologically Active Enantiomers of Chiral Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Indolinones as Promising Scaffold as Kinase Inhibitors: A Review
Mini-Reviews in Medicinal Chemistry